| Ytd | -82.58% | |
| 1y | -87.60% |
| Open | 1.17 | Prev Close | 1.12 | Low | 0.88 | High | 1.68 | Mkt Cap | 5.58M |
| Vol | 858.87K | Avg Vol | 181.21K | EPS | -61.36 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.37 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-09 | 50-d Avg | 2.11 | 200-d Avg | 3.43 | 1yr Est | 0.00 |
LNAI News
On October 9, 2026, Lunai Bioworks, Inc. (the "Company") submitted a formal request to The N
S&P 500 to open higher? Polymarket odds reach 70% as Wall Street digests September jobs, 24-year
Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-m
The Company anticipates reporting a net loss for the fiscal year ended June 30, 2026 of approximatel
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 27.1% to $0.31 during Monday's after-ma
The collaboration is designed to connect patient subtypes identified by BioSymetrics, Lunai's wh
Exclusive worldwide agreement adds human cellular validation to Lunai's AI-driven Parkinson's workfl
5.1-fold enrichment using NIH Tox21 data validates structure-based AChE screening as OpenAI and Anth
Correction Updates a Reference Link; No Other Content in the Original Release Has Changed WILMINGTON
Second Amended Complaint Alleges Securities Fraud and Market Manipulation Under Rule 10b-5 WILMINGTO
New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrate
New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrate
Amended Complaint Alleges 29.6 Million Failed to Deliver Shares and Single Day Trading Volume of 15.
Amended Complaint Alleges 29.6 Million Failed to Deliver Shares and Single Day Trading Volume of 15.
Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar
SACRAMENTO, Calif., June 17, 2026 /PRNewswire/ -- Fellow Shareholders, Over the past several months,
Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expe
Lunai Bioworks Inc. shares soared 80.88% after-hours after regaining Nasdaq compliance with minimum
Lunai Bioworks Inc. shares soared 80.88% after-hours after regaining Nasdaq compliance with minimum
On June 11, 2026, Lunai Bioworks, Inc. (the "Company") received a letter from The Nasdaq St
Lunai Bioworks' (NASDAQ:LNAI) wholly owned subsidiary BioSymetrics and BrainStorm Therapeutics t
Collaboration integrates AI discovery, human brain organoid modeling, and in vivo validation to gene
WASHINGTON, May 22, 2026 /PRNewswire/ -- On Wednesday, May 20, 2026, a United States District Court
SACRAMENTO, Calif., May 20, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (Nasdaq: LNAI) (the "Company")
Lunai Bioworks Inc. - Common Stock (NASDAQ:LNAI) reported quarterly losses of $(0.10) per share. Th
Lunai Bioworks Inc. General Corporate Statement (Form8)Webmaster, Benzinga Editor UNITED STATESSEC
WASHINGTON, D.C. , May 12, 2026 (GLOBE NEWSWIRE) -- via IBN -- On Monday, May 11, 2026, national law
Transaction Adds Dual BBB Delivery Strategies, Supports Alzheimer's Programs, Combination Therapies,
eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, v
(Editor’s note: The futures and ETFs data and headline were updated.) U.S. stock futures were mix
MaxLinear Inc (MXL) shares jump 34.3% in pre-market trading after reporting strong Q1 results and gi
Lunai Bioworks, Inc. (NASDAQ: LNAI) ("Lunai"), an AI-driven drug discovery company, and Gene
Collaboration converts patient-led data into trial-ready cohorts to support drug development, commer
Advancing AI-enabled chemical threat detection and dual-use biodefense technologies through initial
Advancing AI-enabled chemical threat detection and dual-use biodefense technologies through initial